Sol-Gel Technologies Net Change in Investments - Total 2016-2024 | SLGL
Sol-Gel Technologies net change in investments - total from 2016 to 2024. Net change in investments - total can be defined as the total change in long term and short term investments
Sol-Gel Technologies Annual Net Change in Investments - Total
(Millions of US $) |
| 2024 |
$16 |
| 2023 |
$-11 |
| 2022 |
$-7 |
| 2021 |
$20 |
| 2020 |
$19 |
| 2019 |
$16 |
| 2018 |
$-57 |
| 2017 |
$0 |
| 2016 |
$N/A |
| 2015 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.022B |
$0.012B |
|
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
|
